Cowealth Medical China Co.,Ltd. (SHA:603122)
China
· Delayed Price · Currency is CNY 15.25
-0.30 (-1.93%)
At close: Apr 29, 2026
Cowealth Medical China Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -35.93 | -33.64 | 27.57 | 47.19 | 82.72 | 80.23 | Upgrade
|
| Depreciation & Amortization | 8.64 | 8.64 | 8.86 | 10.65 | 11.19 | 14.14 | Upgrade
|
| Other Amortization | 19.52 | 19.52 | 10.07 | 7.11 | 11.93 | 7.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.05 | -0.05 | -0.44 | -0.1 | -0.2 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.02 | 0.02 | 0.36 | 1.06 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.25 | -0.25 | - | -0.07 | -0.64 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 12.7 | 12.7 | -10.24 | -2.88 | 2.47 | 3 | Upgrade
|
| Other Operating Activities | -89.18 | 3.82 | 8.67 | 6.99 | 4.8 | -2.81 | Upgrade
|
| Change in Accounts Receivable | 4.2 | 4.2 | 46.65 | 1.65 | -234.74 | -70.83 | Upgrade
|
| Change in Inventory | -10.67 | -10.67 | -12.06 | 7.44 | -27.21 | -39.57 | Upgrade
|
| Change in Accounts Payable | 20.14 | 20.14 | 49.35 | -64.21 | 121.67 | 10.33 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 0.32 | Upgrade
|
| Operating Cash Flow | -77.61 | 17.68 | 132.75 | 11.28 | -30.37 | 7.01 | Upgrade
|
| Operating Cash Flow Growth | - | -86.68% | 1076.77% | - | - | -90.55% | Upgrade
|
| Capital Expenditures | -13.38 | -14.21 | -31.82 | -67.96 | -25.94 | -22.12 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.16 | 0.8 | 0.12 | 0.47 | 0.03 | Upgrade
|
| Investment in Securities | -119.89 | -129.83 | - | 11.18 | -5.36 | - | Upgrade
|
| Other Investing Activities | 108.42 | 2.72 | 2.13 | 5.01 | 4.92 | 4.67 | Upgrade
|
| Investing Cash Flow | -24.7 | -141.16 | -28.9 | -51.65 | -25.91 | -17.43 | Upgrade
|
| Long-Term Debt Issued | - | 126.97 | 529.67 | 715.34 | 309.72 | 429.21 | Upgrade
|
| Long-Term Debt Repaid | - | -116.16 | -548.02 | -726.43 | -367.14 | -431.08 | Upgrade
|
| Net Debt Issued (Repaid) | 56.31 | 10.81 | -18.36 | -11.09 | -57.42 | -1.86 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 380.6 | - | Upgrade
|
| Common Dividends Paid | -52.36 | -52.66 | -26.95 | -65.25 | -74.54 | -79.65 | Upgrade
|
| Other Financing Activities | 6.48 | 7.33 | -0.17 | -2.54 | -22.92 | -8.09 | Upgrade
|
| Financing Cash Flow | 10.42 | -34.52 | -45.48 | -78.87 | 225.73 | -89.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.94 | -0.91 | 0.25 | -0.39 | 1.17 | -2.44 | Upgrade
|
| Net Cash Flow | -92.83 | -158.91 | 58.63 | -119.63 | 170.62 | -102.46 | Upgrade
|
| Free Cash Flow | -90.99 | 3.47 | 100.93 | -56.68 | -56.31 | -15.11 | Upgrade
|
| Free Cash Flow Growth | - | -96.56% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -13.86% | 0.51% | 10.75% | -5.19% | -4.40% | -1.27% | Upgrade
|
| Free Cash Flow Per Share | -0.20 | 0.01 | 0.26 | -0.14 | -0.15 | -0.05 | Upgrade
|
| Cash Income Tax Paid | 10.43 | 17 | 37.13 | 55.71 | 62.36 | 66.16 | Upgrade
|
| Levered Free Cash Flow | 23.55 | 80.74 | 82.13 | -73.65 | -87.22 | -113.8 | Upgrade
|
| Unlevered Free Cash Flow | 25 | 82.18 | 84.21 | -69.98 | -84.57 | -110.95 | Upgrade
|
| Change in Working Capital | 6.94 | 6.94 | 88.24 | -57.63 | -143 | -96.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.